Boehringer Ingelheim
Overview
Boehringer Ingelheim is a global pharmaceutical company. It is one of the world's largest privately held pharmaceutical companies. The company is committed to researching, developing, manufacturing and marketing novel medications for humans and animals. Its core business areas include human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing.
About Us
Boehringer Ingelheim, founded in 1885 and based in Ingelheim am Rhein, Germany, focuses on discovering and developing innovative therapies to improve human and animal health. The company prioritizes addressing unmet medical needs, investing heavily in research and development to tackle these challenges. Globally active, Boehringer Ingelheim collaborates with academic institutions, research organizations, and other companies to advance scientific knowledge and accelerate the development of novel treatments across various therapeutic areas. These partnerships are crucial to their mission of improving patient outcomes and animal welfare worldwide. Boehringer Ingelheim's commitment to innovation and collaboration drives its efforts to remain a leader in pharmaceutical advancements, delivering impactful solutions to critical health challenges. Their ongoing investment in research and development ensures a robust pipeline of innovative therapies designed to meet the evolving needs of both patients and the veterinary community. This dedication is central to their long-standing commitment to scientific excellence and improving health outcomes globally. By focusing on unmet needs and fostering strategic alliances, Boehringer Ingelheim strives to improve the lives of individuals and animals worldwide, solidifying its position as a leader in the pharmaceutical industry. The company's collaborative approach extends its reach and impact, allowing for a more comprehensive and effective response to global health needs.
Vision
Boehringer Ingelheim's vision is to create value through innovation. They aim to be a leader in innovative treatments for diseases with high unmet medical needs, contributing to a healthier and more sustainable world.
Mission
Improving health and quality of life for humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives.
Headquarters
Mumbai
Specialties & Industries
Open Positions
No open positions at the moment
Check back later for new opportunities